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Amniocentesis is the most common invasive procedure performed during pregnancy 
(Eddleman, et al., 2006). One important factor that women consider when making a decision 
about amniocentesis is the risk of miscarriage associated with the procedure. People use 
heuristics such as anchoring, the action of using a prior belief regarding the magnitude of risk 
as a frame of reference for new information to be synthesized, to better understand risks that 
they encounter in their lives. This study aimed to determine a woman’s perception of 
miscarriage risk associated with amniocentesis before and after a genetic counseling session 
and to determine what factors are most likely to anchor a woman’s perception of miscarriage 
risk associated with amniocentesis. Most women perceived the risk as low or average pre-
counseling and were likely to indicate the numeric risk of amniocentesis as <1% risk. A 
higher percentage of patients correctly identified the numeric risk as <1% post-counseling 
when compared to pre-counseling. However, the majority of patients’ feeling about the risk 
perception did not change after the genetic counseling session (60%), regardless of how they 
perceived the risk before discussing amniocentesis with a genetic counselor. Those whose 
risk perception did change after discussing amniocentesis with a genetic counselor showed a 
decreased risk perception (p<0.0001). Of the multitude of factors studied, only two showed 
significance: having a friend or relative with a personal or family history of a genetic 
disorder was associated with a lower risk perception (p=0.001) and having a child already 
  
was associated with a lower risk perception (p=0.038). The lack of significant factors may 
reflect the uniqueness of each patient’s heuristic framework and reinforces the importance of 
genetic counseling to elucidate individual concerns.  
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BACKGROUND 
Prenatal diagnostic procedures provide insight about fetal health and have become 
routine in obstetrical practice. These procedures provide information about the genetic, 
biochemical, and physiological constitution of the fetus (Eisenberg & Wapner, 2002). 
Amniocentesis is the most common invasive procedure performed during pregnancy 
(Eddleman, et al., 2006). While amniocentesis may be routine, there are several complex 
aspects of the procedure that are explained to women prior to invasive testing (Hunt, de 
Voogd, & Castendeda, 2005). One important factor that women consider is the risk of 
miscarriage associated with amniocentesis. 
 
History and Application of Amniocentesis 
In 1956, Fuchs and Riis first described the potential predictive use of the analysis of 
amniotic fluid. Researchers collected amniotic fluid after membrane rupture to induce labor. 
At this point in history, the usual indications for amniocentesis were therapeutic purposes 
such as reducing amniotic fluid in pregnancies affected by polyhydramnios (Woo, 2007), but 
not for diagnostic reasons. This fluid was analyzed to determine whether Barr bodies could 
be detected in amniocytes present in the amniotic fluid. The ultimate goal of the research was 
to propose a method for determining fetal sex before birth (Fuchs & Riis, 1956).  
Currently, amniocentesis is the most common invasive procedure used during 
pregnancy to detect genetic abnormalities (Eddleman, et al, 2006). Genetic amniocentesis 
determines fetal karyotype and the amount of amniotic fluid alpha-fetoprotein (AFP). 
Amniocentesis can be performed from around 15 weeks of gestation until the end of the 
pregnancy (Kirkham, Harris, & Grzybowski, 2005) and is performed under direct ultrasound 
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guidance using a 20- or 22-gauge spinal needle. Ultrasound is utilized to identify a pocket of 
fluid away from the fetus after which the spinal needle is inserted through the maternal 
abdomen and uterus into the amniotic fluid sac. Approximately 20 cc of amniotic fluid is 
withdrawn and sent for analysis. Fetal cells floating within the amniotic fluid sample are 
grown in tissue culture and karyotyped to determine the presence or absence of a 
chromosome problem (Eisenberg & Wapner, 2002). While the usual focus of amniocentesis 
is to diagnose chromosomal abnormalities, additional indications include measurement of 
AFP for prediction of open neural tube defects, analysis for single gene disorders, 
determination of the presence of infection, and determination of fetal lung maturity (Woo, 
2007).  
As more clinicians began performing amniocentesis, the methodology evolved. In 
1985 Romero et. al. compared two different ways of performing amniocentesis procedure. 
One method, called the sonographically-guided technique, involved the clinician using an 
ultrasound transducer to locate an appropriate area of fluid to sample, removing the 
transducer, and inserting the needle in the selected position. A second method, called 
sonographically-monitored technique, consisted of continuous ultrasound visualization of the 
fluid pocket throughout the procedure. The study determined that when the sonographically-
guided technique was applied, 5.2% of the procedures resulted in a bloody tap and 7.7% 
resulted in a dry tap. In comparison, use of the sonographically-monitored technique resulted 
in 1.2% of these procedures with a bloody tap and 2.0% of these procedures with a dry tap. 
The differences were statistically significant (Romero, et al., 1985). Following these findings, 
many centers began using the sonographically-monitored technique as standard practice 
(Woo, 2007). 
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As with any invasive procedure, amniocentesis is associated with risks to the patient 
and fetus. Risks include complications that could potentially lead to miscarriage, such as 
amniotic fluid leakage, spotting, cramping, and infection (Eisenberg & Wapner, 2002). 
Studies evaluating the risk of a spontaneous abortion associated with amniocentesis have had 
varying results.  
 
Miscarriage Risk Associated with Amniocentesis 
 In the 1970s, studies began to emerge describing the risk for miscarriage with 
amniocentesis. Philip and Bang (1978) reported on data gathered from 1177 pregnant women 
who underwent amniocentesis. Of the women sampled, 28 (2.4%) women experienced a 
spontaneous abortion. The authors reported that about 25% of the women who experienced 
spontaneous abortion underwent the procedure prior to 16 weeks of gestation. Investigators 
also noted that 11 of the 28 women “were probably already at risk of aborting” (Philip & 
Bang, 1978, p. 1184) based on a variety of factors, including bleeding, cervical insufficiency, 
and abnormalities of the placenta. Of the remaining women who experienced a spontaneous 
abortion, 8 (0.70%) women had their first symptom of a miscarriage within three weeks of 
undergoing the procedure. If three weeks following the procedure is considered to be the 
time for a miscarriage to occur, then the authors felt that a miscarriage risk of 0.70% should 
be quoted to women considering amniocentesis. Three women (0.25%) experienced a 
spontaneous abortion within one week of the procedure. If one week is considered a 
reasonable time period for miscarriage risk, then the authors concluded that 0.25% risk 
should be quoted to pregnant women considering amniocentesis. Thus the authors reported 
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the miscarriage rate associated with amniocentesis as 0.3-0.7%.  In this particular study, there 
was no control group (Philip & Bang, 1978).  
An investigational group in Canada also studied the pregnancy loss rate associated 
with amniocentesis. This study examined 1223 amniocenteses performed on 990 pregnant 
women with 1020 pregnancies. Thirty women had amniocenteses performed in two different 
pregnancies occurring during the time period of the study. The control group consisted of 
data gathered from vital statistics records from different national organizations in Canada on 
spontaneous abortions between 16 and 19 weeks gestation at several hospitals in Toronto and 
other Canadian cities. Demographic data was available on all pregnant women in the control 
group. The investigators reported that the incidence of fetal loss after amniocentesis was 
4.7%, which was not statistically different from the loss rate in the control group of 9164 
pregnant women (5.6% and 3.7% miscarriage rates at the two hospitals compared to the 
study group). The researchers concluded that the amniocentesis is a safe procedure for both 
the mother and the fetus (Simpson, et al., 1976).  
Niermeijer et. al. performed a study that followed 350 pregnant women 38 years of 
age or older who underwent amniocentesis between 14 and 16 weeks of gestation (1976). 
Three experienced a spontaneous abortion within one month following the procedure. Of 
these three cases, one of the procedures was performed transvaginally due to placental 
location, one fetus was at risk for Pompe disease (showed deficiency of α-1,4-glucosidase 
activity), and one fetus was conceived by a mother with a balanced translocation (the fetal 
cells failed to grow and were not available for analysis). Based on these considerations and 
other analyses in the study, the authors concluded that the miscarriage risk associated with 
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amniocentesis was ± 1% (Niermeijer, Sachs, Jahodova, Tichelaar-Klepper, Kleijer, & 
Galjaard, 1976).  
Several other studies have indicated a variety of miscarriage rates associated with 
amniocentesis. In 1986, one of the few randomized trials pertaining to amniocentesis was 
conducted. The authors found a miscarriage rate of 1.7% among the group that underwent the 
amniocentesis versus a 0.7% miscarriage rate in the control group. The rate of miscarriage 
among the study group was significantly higher than the control group (Tabor, Madsen, Obel, 
Philip, Bang, & Norgaard-Pedersen, 1986). Subsequent studies have shown risks ranging 
from 0.3% to 0.5%, (Leschot, Verjaal, & Treffers, 1985; Blessed, Lacoste, & Welch, 2001). 
In 1995 the Centers for Disease Control and Prevention (CDC) released a statement 
that reported the risk of miscarriage after amniocentesis to be between 0.25% and 0.5%. This 
risk number was not calculated from a study or publication; rather, a committee at the CDC 
reviewed many different publications that described the miscarriage risk associated with 
amniocentesis and determined a risk number that seemed appropriate to the committee. This 
risk became generalized as the 1 in 200 risk routinely quoted with amniocentesis (Olney, 
Moore, Khoury, Erickson, Edmonds, & Botto, 1995). 
Mujezinovic and Alfirevic (2007) conducted a review of the literature on the risk of 
miscarriage associated with amniocentesis and analyzed various risk figures quoted by 
previous studies. Twenty-nine studies were found to meet criteria for analysis. After dividing 
the findings of these studies into larger groups for analysis, authors concluded that the risk 
for pregnancy loss within 14 days of the procedure was 0.6%, the risk for loss of pregnancy 
before 24 weeks gestation was 0.9%, and the total pregnancy loss after amniocentesis was 
1.9%. The investigators noted that only five of the studies analyzed included control groups. 
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Therefore these numbers do not take into account the background risk for miscarriage 
(Mujezinovic & Alefirevic, 2007).  
In 2007, the American College of Obstetricians and Gynecologists (ACOG) issued a 
practice bulletin summarizing the miscarriage rate associated with amniocentesis after 
reviewing several studies on the subject (ACOG Practice Bulletin No. 88: Invasive Prenatal 
Testing for Aneuploidy, 2007). The committee summarized the miscarriage rate associated 
with amniocentesis as 1/300-1/500. This range of risk figures attempted to capture the 
breadth of miscarriage loss rates as quoted by various studies. This conclusion was based on 
“limited or inconsistent scientific evidence” (ACOG Practice Bulletin No. 88: Invasive 
Prenatal Testing for Aneuploidy, 2007, p. 1465), indicating that previous studies that 
examined the amniocentesis-associated miscarriage rate produced conflicting information 
regarding the exact risk figure.  
Researchers stated the need to assess the miscarriage rate associated with 
amniocentesis using data collected in a large prospective study. The First and Second 
Trimester Evaluation of Risk (FASTER) trial was a large multi-center study that compared 
first trimester and second trimester screening techniques for the detection of Down 
syndrome. The trial collected data from over 35,000 pregnant women in the United States. In 
addition to investigating screening efficacy, data from women who chose to undergo an 
amniocentesis after screening were collected and compared to women in the trial who did not 
undergo an amniocentesis. This study found that the loss rate in the amniocentesis group was 
1/1600 or 0.006% higher than controls. This risk of miscarriage associated with 
amniocentesis was therefore concluded to be much lower than previously estimated 
(Eddleman, et al., 2006). 
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 In response to the data published from the FASTER trial, Alfirevic and Tabor 
published a letter to the editor voicing concerns regarding several of the procedures carried 
out during the study (2007). Afirevic and Tabor commented on the lack of data regarding the 
gauge of the needle used during the amniocentesis. Concerns were raised about the control 
group used in the FASTER trial: according to their reading of the study, the control group 
contained every case of pregnancy loss up to 24 weeks gestation and did not specify the 
gestational week each pregnancy loss occurred (Alfirevic & Tabor, 2007). Alfirevic and 
Tabor commented that individuals in the control group could not be adequately matched to 
individuals who pursued the amniocentesis. The major investigators of the FASTER trial 
amniocentesis study replied to these concerns, stating that an informal poll of many of the 
investigators involved in the trial found that a majority of procedures were performed using a 
22-gauge needle. In addition, the FASTER trial investigators claimed that the second 
statement by Alfirevic and Tabor was incorrect because each of the participants included in 
the analysis was required to complete the entire protocol (all women had a second trimester 
blood draw after 15 weeks of gestation). Therefore the patients had to be pregnant at least 
through 15 weeks and thus the analysis did not include first trimester losses. The trial 
included women who experienced pregnancy loss between gestational weeks 15 and 24, 
which was the time period in which the study group experienced pregnancy loss (Eddleman 
& Malone, 2007).  
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Screening for Aneuploidy 
In the United States, the main indication for discussion of amniocentesis has 
historically been advanced maternal age, or a woman who is age 35 years or greater at the 
time of delivery. The rationale for this indication stems from the increased likelihood of 
women with advanced age to have a child with a chromosomal abnormality, such as Down 
syndrome (ACOG Practice Bulletin No. 77: Screening for Fetal Chromosomal 
Abnormalities, 2007). More recently, ACOG recommended that amniocentesis be offered to 
all pregnant women, regardless of age. This change was made because women at any age can 
have a child with a chromosomal abnormality (ACOG Practice Bulletin No. 88: Invasive 
Prenatal Testing for Aneuploidy, 2007).   
Modern non-invasive screening focuses on biochemical markers in maternal blood 
that can be used to alter the a priori risk of aneuploidy. There are several screening options 
available during pregnancy to aid in the determination of a woman’s risk for having a child 
with a karyotypic abnormality or structural fetal anomaly. An example of a screening 
technique is ultrasound, which examines the physical structures of the fetus to assess for birth 
defects. If a fetus has Down syndrome, soft markers or fetal abnormalities may be identified 
by ultrasound. However, not every pregnancy affected with Down syndrome will have soft 
markers or structural abnormalities. Prior studies describe that sonographic markers or 
abnormalities are detected in approximately 30-50% of fetuses with Down syndrome 
(Rotmensch, et al., 1997; Benacerraf B., 2000).  
Another screening method commonly utilized is second trimester maternal serum 
screening, which measures the levels of various metabolites between fourteen and twenty-
one gestational weeks of pregnancy. Quadruple screening refers to the examination of alpha-
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fetoprotein (AFP), human chorionic gonadotropin (hCG), unconjugated estriol (uE3), and 
inhibin A (DIA) in the mother’s blood.  Second trimester maternal serum screening is the 
most common screening method for Down syndrome in the United States (Malone, et al, 
2005).  Approximately 80% of affected fetuses are detected using the quadruple screen 
(ACOG Practice Bulletin No. 77: Screening for Fetal Chromosomal Abnormalities, 2007).  
 The screening method that has been utilized in more recent years is first trimester 
screening, which can be performed between eleven and thirteen weeks of gestation. First 
trimester screening involves obtaining a nuchal translucency measurement of the fluid behind 
the fetal neck as well as an analysis of the analytes free or total β-hCG and pregnancy-
associated plasma protein A (PAPP-A). The first trimester screen detects approximately 82-
87% of all fetuses with Down syndrome, which is a higher detection rate than second 
trimester screening. One major advantage of the first trimester screening method is that 
women receive information about their risk to have an affected pregnancy at an early stage of 
gestation (ACOG Practice Bulletin No. 77: Screening for Fetal Chromosomal Abnormalities, 
2007).  
 
Conflicting Goals of Amniocentesis 
 Most practicing health care professionals who render obtetrical care view 
amniocentesis as a routine but invasive procedure. However, a study performed by Hunt, de 
Voogd, and Castendeda (2005) revealed that, while health care professionals may view 
prenatal screening and diagnostics as routine, pregnant women faced with the decision about 
whether or not to proceed with this testing do not see the procedures as routine. Hunt 
examined the interactions between pregnant women and their physicians discussing the 
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results of their maternal serum screening test and information regarding the amniocentesis. 
The study found that the health care professionals and patients had drastically conflicting 
views of the purpose and motivations for proceeding with the amniocentesis. Clinicians 
viewed the decision to proceed with amniocentesis as part of an isolated medical algorithm in 
which very little consideration was given to the patient’s personal life or experiences. In 
contrast, the patients viewed the amniocentesis as a way to assure themselves that everything 
in their pregnancy is normal (Hunt, de Voogd, & Castendeda, 2005). The study emphasized 
the stark contrast between patient and clinician motivation for prenatal screening and 
diagnositcs; while both parties claim that these tests promote a healthy pregnancy, it became 
clear in the course of the study that the motivations for using these tests to achieve the goals 
mentioned above were very different. The authors commented that clinicians viewed prenatal 
screening and diagnostic testing as routine and mundane because these tests were often 
performed in the clinican’s office. The patients who were undergoing these screening and 
diagnostic procedures viewed them as momentous and often frightening. These differences in 
viewpoint may be accounted for by considering various heurstics, or risk assessments, that 
are associated with decision making.  
 
Risk Perception  
When an individual evaluates risk, empirical data describing the incidence of the 
event being evaluated is rarely available to them; rather, individuals usually rely on other 
means to judge the riskiness of a situation. This risk judgment is known as a heuristic. While 
simplification of the understanding of risk can be useful in everyday situations, it consistently 
leads to misjudgments regarding the severity of risk. The way a risk is perceived can be 
11 
 
altered by many factors, including the individual’s personal experience with an event or how 
familiar an individual is with the frequency of an event occurring (Slovic, Fischhoff, & 
Lichtenstein, Rating the Risk, 2000).  
Risk perception has been studied in a variety of fields, including geography, 
anthropology, and political science. Research in the domain of psychology has evaluated how 
individuals utilize heuristics to evaluate risk in their life. Factors such as level of 
understanding of a risk and biases incorporated from outside sources affect how a person 
perceives risk (Slovic, The Perception of Risk, 2000).  
 
Anchoring, Representativeness, and Availability  
Amos Tversky and Daniel Kahneman introduced the concepts of anchoring, 
representativeness, and availability in relation to the methodology that a person uses to 
perceive risk (1974). These concepts are specific examples of heuristics that can be used by 
an individual to better understand risks that they encounter in their lives.  
Representativeness describes the situation in which an outcome is assumed to result 
from a process and the individual making the assumption holds to a set of restrictions that the 
individual believes to be true. It is also described as a type of correlation-causation 
assumption; the more often a person experiences event A with event B, the more an 
individual judges events A and B to be related to each other or for one to be caused by the 
other. Representativeness can bias an individual to perceive the riskiness of an event to be the 
same irrespective of the sample size being considered (Tversky & Kahneman, 1974). For 
example, if a woman knows three acquaintances that have undergone amniocentesis and one 
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of them miscarries, she may perceive the risk of miscarriage due to amniocentesis to be one 
in three when in reality the risk is much smaller.  
Availability describes how perception is altered by how easily an event comes to 
mind. For example, if you asked a middle-aged individual the frequency of a heart attack in 
the population, they use examples that they can recall from their own experiences and 
acquaintances to report a probability. Thus, a person’s perception of the risk or probability 
that an event will occur is influenced by their personal experiences and how easily they can 
recall examples in their own lives (Tversky & Kahneman, 1974). Whenever an event is easy 
to imagine or recall, it creates the perception that the event occurs at a greater frequency than 
what empiric data support (Slovic, Fischhoff, & Lichtenstein, Cognitive Processes and 
Societal Risk Taking, 2000).  
Anchoring describes the situation when a person estimates a risk value by first 
considering an initial value (whether correct or not) and adjusting that risk using a variety of 
judgments to result in a final answer. In this heuristic, prior understandings of a given risk 
will ultimately lead to an estimate that is biased towards the initial value. Two avenues 
influence the final risk: the starting risk and the adjustments that are made during the 
evaluation process that produces the final risk calculation (Tversky & Kahneman, 1974). 
Research in this area indicates that when an individual makes a judgment about a risk, the 
adjustments tend to be crude and haphazard. Individuals may not consider the full 
implications of the new information or they may over- or underestimate the importance of the 
new information that is being incorporated in their final risk perception (Slovic, Fischhoff, & 
Lichtenstein, Cognitive Processes and Societal Risk Taking, 2000).  
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Representativeness, availability, and anchoring all play a role in risk perception and 
probability calculation in a wide variety of contexts and applications. While these factors are 
predictably seen in both everyday existence and in formal research, they inevitably lead to 
errors that affect the ways in which a person perceives and evaluates risk. This fact is 
important to consider in clinical applications in which risk perception plays a role (Slovic, 
The Perception of Risk, 2000).  
 
Risk Perception and Genetic Counseling 
The CDC statement addressing the miscarriage rate associated with  amniocentesis 
acknowledged the complexity of the decision to proceed with invasive prenatal diagnostic 
testing (Olney, Moore, Khoury, Erickson, Edmonds, & Botto, 1995). In its statement, the 
committee urged health care professionals to discuss the various aspects of this decision with 
patients, including maternal age and family history. The statement also recommended that the 
benefits, risks, and limitations of amniocentesis be discussed in depth with patients so that 
each pregnant woman has the adequate knowledge necessary to make an informed decision 
regarding prenatal diagnosis (Olney, Moore, Khoury, Erickson, Edmonds, & Botto, 1995). 
Although the committee’s task was to empirically assess the miscarriage rate associated with 
prenatal diagnostic procedures, it also emphasized the importance of taking all factors into 
consideration before proceeding with an invasive prenatal procedure. This statement 
acknowledged that a decision regarding a potentially devastating outcome for a pregnant 
woman should be weighed against other factors besides the simple empiric risk of 
miscarriage associated with the procedure (Olney, Moore, Khoury, Erickson, Edmonds, & 
Botto, 1995).  
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 A recent study by Stevens et. al. (2008) investigated whether women perceived a 
difference between a range of risk figures associated with amniocentesis. This study 
attempted to determine which factors influence risk perception the most and at what risk 
level women were most comfortable with proceeding with an amniocentesis. In addition, 
Stevens et. al. examined a variety of factors that have the potential to influence a woman’s 
perception of miscarriage risk associated with amniocentesis including parity, utilization of 
maternal serum screening, and previous children born with a birth defect. Stevens found that 
participants did interpret the range of risk figures as different and were more likely to wish to 
proceed with an amniocentesis when the risk of miscarriage was quoted at a lower figure. 
Additionally, none of the demographic factors were significantly associated with an 
amniocentesis decision. This study highlighted the concept that the quoted miscarriage risk 
figure is an important part of the decision-making process regarding the uptake of 
amniocentesis. However, Stevens et. al. noted that by placing all of the risk figures together, 
the participants may have been anchored to the lowest risk of miscarriage quoted. The 
majority of participants generally understood which risk figure was lowest and thus may 
have been influenced to select the lowest choice because they were comparing it to higher 
risks. The authors suggest that further study is needed to determine how women perceive 
various miscarriage risks associated with amniocentesis without being influenced by a range 
of figures. 
 
Anchoring and Risk Perception Associated with Amniocentesis 
Although there is a quantitative risk for miscarriage with amniocentesis, this 
information may not be the only factor that influences a woman’s perception of the 
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miscarriage risk. Anchoring, or the prior perception that serves as the frame of reference for 
new information, may have a great impact on the perception of risk. For women who 
participate in a prenatal discussion regarding amniocentesis and miscarriage risk, anchoring 
may have a profound impact on their risk perception that is independent of the numeric risk 
quoted by a genetic counselor or physician. A woman’s previous experience with 
amniocentesis or the experiences of individuals whom she knows may serve as the frame of 
reference for her perception of the miscarriage risk.  To date, no study has specifically 
examined the influence that anchoring effects have on the perception of miscarriage risk 
associated with the amniocentesis. Therefore, this study aims to determine what factors are 
most likely to anchor a woman’s perception of miscarriage risk associated with 
amniocentesis and to determine a woman’s perception of miscarriage risk associated with 
amniocentesis before and after a genetic counseling session. This information may help both 
physicians and genetic counselors alike to better understand the influence that previous 
perceptions regarding the miscarriage risk have on the uptake of amniocentesis. 
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MATERIALS AND METHODS 
Study Recruitment 
 Surveys were offered to pregnant women who were attending prenatal appointments 
at a University of Texas affiliated high-risk pregnancy clinic and met eligibility 
requirements. In order to be eligible, the patient’s indication had to involve the possibility of 
having an amniocentesis performed and included advanced maternal age and abnormal serum 
screen results. Patients were eligible to participate if they were also at least 18 years of age, 
spoke English, and were being seen at an IRB approved satellite clinic in the Houston, Texas 
area associated with the University of Texas Medical School at Houston, Department of 
Obstetrics, Gynecology, and Reproductive Sciences Division of Maternal Fetal Medicine: 
University of Texas Professional Building, Memorial Hermann Memorial City, Memorial 
Hermann Katy, Memorial Hermann Southeast, Memorial Hermann Southwest, and Memorial 
Hermann Sugar Land. A letter of invitation was given to eligible women. Those who chose 
to participate completed a two-part anonymous survey. Participants were recruited from 
September 14, 2009 to February 12, 2010.  
 
Survey Instrument 
 An anonymous survey was developed to assess women’s attitudes and perceptions 
about the miscarriage risk associated with amniocentesis. The survey was divided into three 
major portions. Each survey had a unique identifying number that was written onto each 
portion in order to match them during data analysis. The first portion was given to women 
while they waited for their genetic counseling appointment and provided a brief description 
of the amniocentesis and asked women about their perception of the miscarriage risk 
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associated with amniocentesis, including questions that asked women to quantify the risk of 
miscarriage and rate their feelings about this risk (see Appendix A). The first portion also 
requested information about the participant’s personal history, medical history, pregnancy 
history, and personal experience with various friends and family members who may have a 
genetic disorder. The second portion of the survey was administered after the genetic 
counseling session and asked participants to again quantify the risk of miscarriage associated 
with the amniocentesis and rate their feelings about the riskiness of the procedure (see 
Appendix B). This portion also asked women whether or not they were planning to undergo 
the amniocentesis and asked them to explain the reasons for their decision. The third portion 
of the survey was completed by the genetic counselor after the counseling session (see 
Appendix C). This portion asked the counselor to identify the various factors that they 
believed influenced the patient’s decision whether or not to proceed with the amniocentesis. 
The counselor also provided pregnancy history information about the patient.  
 The protocol was submitted to the institutional review board of the University of 
Texas Health Science Center Memorial Hermann Healthcare System and approved via 
expedited review (UT IRB HSC-MS-09-0365).  
 
Survey Administration 
 A letter of invitation was given to eligible women when they arrived at the clinic (see 
Appendix D). When the patient elected to participate and completed the first portion of the 
survey, the front desk personnel placed the letter of invitation into the patient’s chart so that 
the genetic counselor would be aware that the patient had completed a survey. The completed 
survey section was placed in a separate collection box. This method ensured that the 
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counselor would not be biased by the patient’s responses on the first portion of the survey. 
The letter of invitation was given back to the participant after the completion of the genetic 
counseling session if requested so that the participant could have more information about the 
study.  After the counseling session was completed, the counselor led the patient to the 
waiting room and gave the patient the second portion of the survey. While the patient waited 
for their ultrasound, they completed the second portion of the survey. The second portion was 
collected by the front desk personnel or ultrasonographer. The third portion of the survey was 
completed by the counselor after the session. Survey portions were later matched by their 
unique identifying number.  
 
Statistical Analysis 
 The survey response fields were coded and data was entered into a Microsoft Excel 
spreadsheet. Statistical analysis was performed using STATA software. Information coding 
for the numeric risk figure before and after counseling was converted from proportion out of 
1000 to a percentage. These percentages were used in all subsequent analysis evaluating 
differences in risk quantification. Distribution of demographic variables (race, education, 
income, and religion) was described.  
The perception of risk before counseling and after counseling was evaluated with 
respect to various factors including personal experience with amniocentesis, having a friend 
or relative with a genetic disease, and pregnancy information. Contingency tests were used to 
evaluate the differences in frequencies of each risk perception category for all the above 
factors.  
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Changes in risk perception from before to after counseling were also calculated. 
Wilcoxon signed rank test was used to compare the magnitude and direction of these changes 
after stratification by the factors mentioned above.  
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RESULTS 
 Data was gathered via surveys that were administered in three main sections. The first 
two sections of the survey were completed by the patient and the third section was completed 
by the genetic counselor following the session. One hundred thirteen first sections, 104 
second sections, and 110 third sections were returned. Ninety-nine surveys had all three 
sections completed. 
 It will be noted in several of the following tables and figures that not every question 
was completed by every participant, thereby making the sample size of certain tables smaller 
than the sample sizes noted above. All percentages reflect the number of participants who 
chose an answer out of the total for a given question. In addition, whenever comparisons 
were made between risk perception and a given factor, the sample size noted represents those 
who answered both the perception question and the question about the given factor.  
 
Demographics 
 Participants were asked to indicate their race (Table 1), education level (Table 2), 
total household income (Table 3), and religion (Table 4a). All those who indicated their 
religion as “other” had the opportunity to write a description of their religion. Forty-one of 49 
participants who checked “other” and wrote a description indicated items such as 
“Christian,” “Baptist,” or “Methodist,” which were all grouped together under Protestantism. 
One participant indicated that her religion was “Catholic/Jewish.” Six participants left the 
field blank, and 1 wrote “n/a”. These 7 participants were grouped together in the category 
“Other” while the 41 non-Catholic Christian denominations were grouped in the category 
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Protestant. Therefore the actual percentage of participants who were Protestant was 51.88% 
(Table 4b). The groupings in Table 4b were used in future comparisons. 
Table 1. Demographics: Race 
 
 
Table 2. Demographics: Education 
Education n=111 Percent 
Some HS 8 7.21% 
HS 25 22.52% 
Some College 29 26.13% 
College 34 30.63% 
Grad School 15 13.51% 
 
 
 
 
 
 
Race n=111 Percent 
AA  27 24.32% 
Hispanic 29 26.13% 
Asian 10 9.01% 
Caucasian 39 35.14% 
Other  6 5.41% 
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Table 3. Demographics: Income 
Annual Income n=100 Percent 
<$30K 34 34% 
$30-60K 27 27% 
$60-100K 16 16% 
>$100K 23 23% 
 
Table 4a. Demographics: Religion 
Religion n=106 Percent 
Protestant 14 13.21% 
Catholic 27 25.47% 
Jewish 1 0.94% 
Muslim 4 3.77% 
Buddhist 1 0.94% 
Hindu 3 2.83% 
None 7 6.6% 
Other 49 46.23% 
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Table 4b: Demographics: Religion Revised  
Religion n=106 Percent 
Protestant 55 51.88% 
Catholic 27 25.47% 
Jewish 1 0.94% 
Muslim 4 3.77% 
Buddhist 1 0.94% 
Hindu 3 2.83% 
None 7 6.60% 
Other (blank) 7 6.60% 
Other (non- 
Protestant) 
1 0.01% 
 
Miscarriage Risk Quantification Before Counseling 
Before the genetic counseling session, patients were given the opportunity to indicate 
how many women out of 1000 they believed would miscarry following the amniocentesis or, 
if the patient preferred, to indicated the percentage of women who would miscarry following 
an amniocentesis. Twenty-six total responses were indicated on the first portion of the survey 
for the miscarriage number and 29 total responses were recorded for the percentage of 
women who would miscarry due to the amniocentesis. Patients provided a wide variety of 
responses. Lists of responses are in Tables 5 and 6.  
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Table 5. Numeric Risk Before Counseling 
Number/1000 n=26 
0 1 
1 7 
2 2 
2-3 2 
3 1 
5 3 
10 1 
15 1 
20 4 
50 1 
100 2 
250 1 
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Table 6. Percentage Risk Before Counseling 
Percent n=29 
0 1 
0.003 1 
<1/2 1 
0.5 1 
1 5 
1-2 2 
2 5 
3 3 
4 1 
5 4 
7 1 
10 1 
25 1 
40 1 
60 1 
 
In order to simplify the examination of the quantification of miscarriage risk 
perception before counseling, all of the responses given in numerical form were converted to 
percentages and combined with the data of participants who answered the question in 
percentage form. Ranges of these percentages were formed for ease of analysis. In the first 
portion of the survey, 8 participants answered with both a number and a percentage. Both 
number and percentage values are reflected in Tables 5 and 6. However, only
values were used in the data in Figure 1, which examines general trends of risk quantification 
before counseling. Figure 1 shows that most of the participants (n=27) believed the risk to be 
between 0-1%.  
 
Figure 1. Miscarriage Risk Quantif
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 Figure 2. Perception of Miscarriage Risk Before Counseling
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to view the risk as low or average. A total of 60 participants completed the survey item that 
assessed whether or not someone offered them a suggestion about amniocentesis. Those who 
indicated that they were told not to pursue amniocentesis (n=23) tended to view the risk as 
low (n=4), average (n=9), or high (n=5) those who were told to undergo amniocentesis 
(n=20) tended to view the risk as very low (n=8) or low (n=7), and those who said that the 
person did not give a suggestion (n=17) considered the risk as almost equally low (n=5), 
average (n=5), and high (n=4).  
 
Table 7. Comparison of Miscarriage Risk Perception Before Counseling and Patient 
Discussions with Various Individuals  
Comparison of Factors n p-value 
Discuss with Doctor 51 p = 0.090 
Discuss with Husband 39 p = 0.603 
Discuss with Mother 20 p = 0.404 
Discuss with Friend 27 p = 0.615 
Discuss with Coworker 13 p = 0.056 
Discuss with Sister 10 p = 0.158 
Discuss with Other  7 p = 0.235 
Discuss with No One 9 p = 0.175 
Person made an Amnio suggestion 60 p = 0.077 
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Table 8 indicates that, of the people who report having genetic counseling before, 
most were seen for advanced maternal age. One participant indicated that they had had 
genetic counseling but they did not mark an indication, and one participant indicated that 
they had had genetic counseling in the past but indicated that they had been seen for AMA 
and for “other” indication. There were no significant differences seen between women with 
previous genetic counseling and those without genetic counseling. 
 
Table 8: Comparison of Miscarriage Risk Perception Before Counseling and Personal 
Experience with Genetic Counseling (GC) 
Comparison of Factors 
 
n p-value 
Patients w/ previous genetic counseling 
 
13 p= 0.233 
Previous GC for AMA 
 
7 p= 0.341 
Previous GC for  Pos DS 
 
1 p = 0.361 
Previous GC for  Fam Hx 
 
1 p = 0.214 
Previous GC for Other Indication 
 
5 p = 0.548 
 
Table 9 shows whether the way in which patients have obtained educational 
information about amniocentesis influences their risk perception. Participants were asked to 
indicate all sources they utilized. The majority of women who indicated they had obtained 
educational information about amniocentesis indicated doing so either via a book or the 
Internet. No factors were found to be statistically significant.  
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Patients were asked to indicate their personal experience with a genetic disease or 
birth defect and could indicate more than one response. When analyzing whether having a 
personal experience with genetic disease and birth defects influences risk perception (Table 
10), there was a statistically significant difference between miscarriage risk perception and 
whether or not the patient had a friend, relative, or coworker with a child or a personal 
history of a genetic disease (p=0.001). If a participant knew a friend, relative, or coworker 
with a personal history or a child with a genetic disease (n=24), they tended to view the risk 
of miscarriage as lower than those who did not know a person with this history.  In looking 
further at whether it mattered what type of friend or relative had the genetic condition, we 
compared specific relationships to those who did not know anyone with a genetic disease 
(n=47; table 10).  Two specific relationships were found to be statistically significant: 
knowing a friend with a genetic disease (p=0.013) and knowing another relative with a 
genetic disease (p=0.025). These individuals were more likely to view the risk as low. 
 
Table 9. Comparison of Miscarriage Risk Perception Before Counseling and  
Previous Education about Amniocentesis 
Comparison of Factors n p-value 
Learned about Amnio via book 25 p = 0.753 
Learned about Amnio via Pamphlet 9 p = 0.231 
Learned about Amnio via Web 33 p = 0.384 
Learned about Amnio via None 23 p = 0.739 
Learned about Amnio via Other  5 p = 0.132 
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Patients were asked to indicate their personal experience with a genetic disease or 
birth defect and could indicate more than one response. Analysis was conducted to compare 
respondents to all those who did not indicate the answer being analyzed. When analyzing 
whether having a personal experience with genetic disease and birth defects influences risk 
perception (Table 10), the only statistically significant factor was the difference between 
miscarriage risk perception and whether or not the patient had a friend, relative, or coworker 
with a child or a personal history of a genetic disease (p=0.001). If a participant knew a 
friend, relative, or coworker with a personal history or a child with a genetic disease (n=24), 
they tended to view the risk of miscarriage as lower than those who did not know a person 
with this history. In looking further at whether it mattered what type of friend or relative had 
a genetic condition, one factor approached significance: the patient had a friend with a 
genetic disease (p=0.060). Those who have a friend with a genetic disease or a child with a 
genetic disease (n=11) were more likely to view the risk as low (n=6). 
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Table 10. Comparison of Miscarriage Risk Perception Before Counseling and Personal 
Experience with Genetic Disease and Birth Defects 
Comparison of Factors 
 
n p-value  
Know a friend with child/personal hx 
of genetic disease 
 
24 p = 0.001 
     Friend genetic disease hx 
 
11 p = 0.013 
     Mother genetic disease hx 
 
1 p = 0.201 
     Sister genetic disease hx 
 
1 p = 0.422 
     Sister in law genetic disease hx 
 
1 p = 0.422 
     Another relative genetic disease hx 
 
7 p = 0.025 
    Coworker genetic disease hx 
 
2 p = 0.390 
    Other genetic disease hx 
 
7 p = 0.095 
 
Table 11 summarizes the participants’ personal experience with amniocentesis. The 
sample sizes do not sum to the correct number because one participant marked that she had 
not had an amniocentesis in a previous pregnancy, yet also marked that the amniocentesis 
results revealed trisomy 18. Several p-values were not calculated due to small sample sizes. 
No factors were found to be statistically significant.  
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Table 11. Comparison of Risk Perception Before Counseling and Personal Experience 
with Amniocentesis 
Comparison of Factors 
 
n p-value  
Had Amnio in Previous Pregnancy 9 p = 0.868 
     Previous Amnio Results were normal 5 Not calculated 
     Previous Amnio Results were DS 1 Not calculated 
     Previous Amnio Results were Tri 18 1 Not calculated 
     Previous Amnio results were other 3 Not calculated 
Complications after Amnio 2 p = 0.532 
     Bleeding following Amnio 1 Not calculated 
     Other complication following Amnio 1 Not calculated 
Friend/Relative had Amnio  25 p = 0.853 
     Friend had Amnio 19 p = 0.917 
     Mother had Amnio 2 p = 0.813 
     Sister had Amnio 1 p = 0.361 
     Sister in Law had Amnio 1 p = 0.603 
     Another family member had Amnio 3 p = 0.239 
     Cowork had Amnio 5 p = 0.177 
     Other had Amnio 2 p = 0.813 
Problem shown on friend’s Amnio 3  p = 0.138 
Friend had complication after Amnio 1 p = 0.521 
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Demographic information is summarized in Table 12; no factors were found to be 
statistically significant.  
 
Table 12. Comparison of Miscarriage Risk Perception Before Counseling and 
Demographics 
Comparison of Factors 
 
n p-value 
Race 
 
74 p= 0.848 
Education 
 
74 p = 0.658 
Income 
 
69 p= 0.551 
Religion 
 
72 p = 0.645 
 
 Table 13 indicates factors involving participants’ pregnancy and family size 
information. Pregnancy information was collected from the third portion of the survey that 
was completed by the genetic counselor to help ensure accuracy. The sample size for each 
factor represents how many data points were available for analysis, not the total number of 
pregnancies. The only statistically significant factor was the number of total living children a 
participant had (p=0.038). Women who had one living child (n=28) were more likely to 
indicate a risk on the lower end of the range. Participants who had more than two living 
children were included in the analysis, but these sample sizes were much smaller and did not 
show an obvious trend.  
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Table 13. Comparison of Miscarriage Risk Perception Before Counseling and 
Pregnancy and Child Information (collected by genetic counselor) 
Comparison of Factors n n=0 n=1-2 n=3+ p-value 
Total pregnancies 70 0 32 38 p = 0.670 
Total living children 70 15 45 10 p = 0.038 
Total miscarriages 69 47 18 4 p = 0.759 
Total abortions/terminations 70 54 15 3 p = 0.104 
Total stillbirths 70 68 2 0 p = 0.317 
Previous child with a birth defect 10 n/a n/a n/a p = 0.115 
 
 
Miscarriage Risk Quantification After Counseling 
Participants were asked to quantify the miscarriage risk associated with amniocentesis after 
they had received genetic counseling. Sixty-five total responses were recorded in the format 
where the participant indicated the number of women out of 1000 and 43 total responses 
were completed for the percentage of women that would miscarry because of the 
amniocentesis. A list of the responses is compiled in Tables 14 and 15.  
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Table 14. Numeric Risk After Counseling 
Number/1000 n=65 
0 1 
0.0005 1 
1 11 
1/3 1 
1/300 4 
1/500 1 
10 1 
100 1 
2 4 
20 2 
3 20 
3.25 1 
3.3 2 
3.5 3 
3/100 1 
30 1 
300 2 
4 1 
5 2 
50 4 
6 1 
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Table 15. Percentage Risk After Counseling 
Percentage n=43 
1/300 1 
0.05 1 
0.3 1 
0.5 3 
<1% 2 
1 12 
1.5 1 
1.99 1 
2 6 
2.5 2 
3 2 
5 1 
10 3 
30 2 
60 1 
90 1 
95.2 1 
98 1 
99 1 
 
 
As with the first portion of the survey, all of the responses were converted to 
percentages and put into ranges for ease of comparison. For this question, 18 participants 
answered both with a numeral and a 
indicated by the participant was used in the comparison. Figure 3 indicates that the vast 
majority of patients believed that the risk was between 0
 
Figure 3. Miscarriage Risk Quanti
 
 
 Figure 4 illustrates the comparison of miscarriage risk quantification before and after 
the counseling session. The percentage of each set of responses (before counseling and after 
counseling) are indicated on the graph. Most patients, both before and after counseling, 
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a statistically significant difference between risk quantification before and after coun
(p<0.0001) such that more participants indicated the correct numeric range post
 
Figure 4. Comparison of Miscarriage Risk Quantification Before and After Counseling 
(Percentages) 
 
Miscarriage Risk Perception After Genetic Counseling an
 A total of 100 participants indicated their perception of the amniocentesis miscarriage
risk after genetic counseling i
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Figure 5. Perception of Miscarriage Risk After Counseling
  
Miscarriage risk perception after counseling was compared to
None of the factors were found to be statistically significant (Table 1
 
Table 16. Comparison of Risk Perception After Counseling and Demographics
Comparison of Factors 
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The second portion of the survey was analyzed to examine factors potentially 
influencing risk perception. Analysis revealed that there was a statistically significant 
difference between miscarriage risk perception after genetic counseling and the patient’s plan 
about whether or not to proceed with amniocentesis (p=0.017). In general, those who desired 
to proceed with amniocentesis usually viewed miscarriage risk as lower than those who did 
not elect amniocentesis (Table 17). 
 
Table 17. Comparison of Miscarriage Risk Perception After Counseling and 
Amniocentesis Plan 
 Amniocentesis Decision  
Perception No Yes Unsure Totals 
Very Low 5 17 3 25 
Low 10 10 8 28 
Average 10 7 3 20 
High 8 2 3 13 
Very High 5 1 0 6 
Totals 38 37 17 92 
 
 
Table 18 presents information about those who chose to proceed with amniocentesis 
and their reasons for desiring amniocentesis. Participants could select as many survey items 
as they desired. There was a statistically significant association between reduced miscarriage 
p-value = 0.017 
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risk perception and patients who chose to proceed with the amniocentesis because they 
needed to know whether or not the pregnancy had a chromosomal condition (p=0.015).  
 
Table 18. Comparison of Miscarriage Risk Perception After Counseling and 
Participants who Did Proceed with Amniocentesis  
Comparison of Factors n p-value 
Patient needed to know whether pregnancy had a 
chromosomal condition 
34 p = 0.015 
The risk assoc. with Amnio is low 11 p = 0.296 
Patient had Amnio in previous pregnancy 4 p= 0.429 
Other reason for proceeding with Amnio  1 p = 0.553 
 
Of those participants who decided not to proceed with amniocentesis,  one item was 
statistically significant: those who chose not to proceed with the amniocentesis because the 
patient felt the risk of miscarriage associated with amniocentesis was too high (p=0.004) 
(Table 19). Most people who indicated they did not want to proceed with amniocentesis 
(n=18) for this reason perceived the risk as average (n=7) or high (n=5).  
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Table 19. Comparison of Miscarriage Risk Perception After Counseling and 
Participants who Did Not Proceed with Amniocentesis 
Comparison of Factors n p-value 
The risk assoc. with Amnio is too high 18 p = 0.004 
Patient does not like needles  9 p = 0.131 
Does not matter to patient if pregnancy has 
chromosomal condition 
12 p = 0.965 
Patient’s friend had problem w/ Amnio 1 p = 0.670 
Patient does not know what Amnio can tell 
her 
1 p = 0.670 
 Patient does not believe pregnancy has a 
problem  
12 p = 0.683 
 
Finally, we examined data from those who indicated they were unsure about 
amniocentesis (Table 20). None of the factors examined were found to be significant.  
 
Table 20. Comparison of Miscarriage Risk Perception After Counseling and 
Participants who were Unsure about proceeding with Amniocentesis 
Comparison of Factors n p-value 
The patient wanted to discuss 
Amniocentesis with Husband/Partner  
4 p= 0.813 
The patient wanted to wait for the results of 
the ultrasound  
21 p = 0.098 
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There were a total of six prenatal counselors involved in counseling the study 
participants. Risk perception after counseling was compared to the counselor who facilitated 
the session. There was no difference found between counselors (p=0.723). In 13 cases, the 
majority of the genetic counseling session was performed by a second year genetic 
counseling student. There was no significant difference between the risk perceptions of 
patients who were counseled by students instead of counselors (p=0.906).  
 
Change in Miscarriage Risk Perception Before and After Genetic Counseling 
A comparison was made between the responses of all 65 participants who indicated a 
risk perception before counseling and any participant who indicated their perception after the 
genetic counseling session. There was a statistically significant difference between the risk 
perception before and after the genetic counseling session (p<0.0001). Additionally, analysis 
using Wilcoxon signed rank test was obtained to determine the differences between the risk 
perception before and after the genetic counseling session. This analysis also yielded a 
statistically significant result (p=0.022). Therefore, participants perceived the miscarriage 
risk associated with amniocentesis as lower after genetic counseling.  
 We compared the degree to which the genetic counseling session changed the way 
participants perceived the miscarriage risk of amniocentesis. Figure 6 illustrates the total 
change indicated by participants. A negative change indicates that the patient perceived the 
risk as lower on the Likert scale after the counseling session compared to their perception 
before counseling, whereas a positive change denotes that a participant felt the risk was 
higher after the session. A majority of patients did not change their perception after the 
counseling session (60%) or changed their perception to a slightly lower risk (26.2%).  
 Figure 6. Change in Risk Perception 
 
  
 We examined whether the initial risk category influenced how much the patient’s risk 
perception changed. Figure 7 illustrates that, in general, women did not change their 
perception regardless of category. However, of those who did change their risk percep
after counseling, most generally moved to a lower level of risk perception about 
amniocentesis.  
 
 
 
 
 
0
5
10
15
20
25
30
35
40
-4 -3
0
(0.0%)
1
(1.5%)Nu
m
be
r 
o
f P
a
rt
ic
ip
a
n
ts
-2 -1 0 +1 +2 +3
2
(3.1%)
17
(26.2%)
39
(60%)
4
(6.2%) 2(3.1%) (0.0%)
Change in Risk Perception
45 
 
 
tion 
+4
0 0
(0.0%)
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Table 21. Comparison of Change in Risk Perception and Demographic Factors 
Comparison of Factors n p-value 
Race 65 p = 0.706 
Education 65 p = 0.798 
Income 60 p = 0.850 
Religion 63 p = 0.999 
 
Table 22. Comparison of Change in Risk Perception and Patient Discussions with 
Various Individuals 
Comparison of Factors n p-value 
Discuss with Dr. 45 p = 0.678 
Discuss with Husband 35 p= 0.530 
Discuss with Mother 20 p = 0.517 
Discuss with Friend 23 p = 0.381 
Discuss with Coworker 11 p = 0.941 
Discuss with Sister 9 p = 0.703 
Discuss with Other  7 p = 0.461 
Discuss with No One 7 p = 0.538 
Person made an Amnio suggestion 22 p= 0.824 
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Table 23. Comparison of Change in Risk Perception and Personal Experience with 
Genetic Counseling 
Comparison of Factors 
 
n p-value 
Patients w/ previous genetic counseling 
 
11 p = 0.854 
Previous GC for AMA 
 
5 p = 0.950  
Previous GC for  Pos DS 
 
1 p = 0.984 
Previous GC for  Fam Hx 
 
1 p = 0.984 
Previous GC for Other Indication 
 
5 p = 0.946 
 
Table 24. Comparison of Change in Risk Perception and Previous Education about 
Amniocentesis 
Comparison of Factors n p-value 
Learned about Amnio via book 21 p = 0.335 
Learned about Amnio via Pamphlet 7 p = 0.795 
Learned about Amnio via Web 30 p = 0.273 
Did not learn about Amnio  21 p = 0.084 
Learned about Amnio via Other  3 p = 0.836 
 
 
 
 
 
49 
 
When change in risk perception was compared to personal experience with genetic 
disease, the only factor found to be significant was if the participant knew another person not 
specified in the choices listed who had some sort of personal history with genetic disease 
(p=0.036); (Table 25). Of the 5 who responded, three did not change their risk perception and 
two increased their risk perception by one unit. Respondents tended to think that the risk 
associated with amniocentesis before counseling was very low (n=2) or low (n=2). No 
significance was seen between change in risk perception and personal experience with 
amniocentesis (Table 26). Some p-values were not calculated due to the small sample sizes in 
the groups indicated.  
 
Table 25. Comparison of Change in Risk Perception and Personal Experience with 
Genetic Disease and Birth Defects 
Comparison of Factors 
 
n p-value  
Know a friend with child/personal hx of 
genetic disease 
 
21 p = 0.214 
     Friend genetic disease hx 
 
11 p = 0.254 
     Mother genetic disease hx 
 
1 p = 0.984 
     Sister genetic disease hx 
 
1 p= 0.984 
     Sister in Law genetic disease hx 
 
1 p = 0.984 
     Another fam mem genetic disease hx 
 
6 p= 0.883 
     Coworker genetic disease hx 
 
2 p = 0.979 
     Other genetic disease hx 
 
5 p = 0.036 
Child with birth defect  
 
7 p = 0.843 
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Table 26. Comparison of Change in Risk Perception and Personal Experience with 
Amniocentesis 
Comparison of Factors 
 
n p-value  
Had Amnio in Previous Pregnancy 6 p = 0.901 
     Previous Amnio Results were normal 5 Not calculated 
     Previous Amnio Results were DS 0 Not calculated 
     Previous Amnio Results were Tri 18 1 Not calculated 
     Previous Amnio results were other 2 Not calculated 
Complications after Amnio 1 p = 0.905 
     Bleeding following Amnio 1 Not calculated 
     Other complication following Amnio 0 Not calculated 
Friend/Relative had Amnio  21 p = 0.664 
     Friend had Amnio 16 p = 0.865 
     Mother had Amnio 1 p = 0.984 
     Sister had Amnio 1 p = 0.984 
     Sister in Law had Amnio 1 p = 0.702 
     Another Family member had Amnio 3 p = 0.991 
     Cowork had Amnio 5 p = 0.946 
     Other had Amnio 1 p = 0.720 
Problem shown on friend’s Amnio 3  p = 0.416 
Friend had complication after Amnio 1 p = 0.458 
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When comparing risk perception change and pregnancy history (Table 27), two 
factors were found to be significant: total number of living children (n=64; p=0.002) and 
total number of still births (n=64; p=<0.001). Parity was distributed among a large number of 
responses (from 0 to 5 living children), making it difficult to determine an obvious trend. 
Only 2 women had a history of stillbirth. 
 
Table 27. Comparison of Change in Risk Perception and Pregnancy and Child 
Information 
Comparison of Factors n n=0 n=1-2 n=3+ p-value 
Total pregnancies 64 0 30 34 p = 0.167 
Total living children 64 13 43 8 p = 0.002 
Total miscarriages 64 42 18 4 p = 0.306 
Total abortions/terminations 64 49 14 1 p = 0.203 
Total stillbirths 64 62 2 0 p = <0.0001 
Previous child with a birth 
defect 
8 n/a n/a n/a p = 0.652 
 
  
52 
 
DISCUSSION 
 Amniocentesis is the most common invasive procedure performed during pregnancy 
(Eddleman et. al. 2006). There is a risk of miscarriage associated with amniocentesis. This 
risk has been quoted as high as 1/200 (Olney, Moore, Khoury, Erickson, Edmonds, & Botto, 
1995) to as low as 1/1600 (Eddleman et. al. 2006). Typically, a woman who is considering 
undergoing amniocentesis will discuss the risks, benefits, and limitations with a 
knowledgeable health care professional. Regardless of the specific risk of miscarriage 
quoted, patients bring their own perception of the risk to the discussion. The purpose of the 
current study was to determine what factors potentially anchor a woman’s perception of the 
miscarriage risk. 
 
Miscarriage Quantification and Risk Perception Before Counseling  
Participants were asked to quantify the risk of miscarriage associated with 
amniocentesis before they spoke with a genetic counselor. Over half of the women (57%; 
n=27) responded that they believed the risk to be 1% or less while 14.8% (n=7) thought the 
risk was 1.1-2% and 17% (n=8) thought the risk was 2.1-5%. The remaining 5 participants 
indicated the risk as larger than these ranges. These results indicate that, while many women 
may not know the exact risk of miscarriage, approximately half estimate the risk similar to 
the risks quoted in the literature (ACOG Practice Bulletin No. 88: Invasive Prenatal Testing 
for Aneuploidy, 2007; Eddleman et. al., 2006). However, a significant portion of women 
overestimate the numeric risk associated with amniocentesis. Thus genetic counselors and 
maternal fetal specialists have a role in rectifying the understanding of a substantial number 
of patients.  
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 When asked to rate how they perceive the risk on a Likert scale of very low to very 
high, most women indicated that they perceived the risk of miscarriage as average (29.7%; 
n=22) to low (27%; n=20) before counseling. There was a generally normal distribution 
across the risk perception scale. These results indicate that most women view amniocentesis 
as a procedure with moderate to limited risk involved. Given that individuals may over- or 
underestimate the importation of new information when altering their original risk 
perception, understanding the risk perception brought to the genetic counseling session is 
essential (Slovic, Fischhoff, & Lichtenstein, Cognitive Processes and Societal Risk Taking, 
2000). 
 
Factors that Potentially Anchor Miscarriage Risk Perception Before Counseling 
When multiple comparisons were made between risk perception and various factors 
postulated to cause anchoring, only two variables were statistically significant: connection to 
a genetic condition and parity. Of those who indicated that they knew a person with a 
personal history of a genetic disease or a child with a genetic disease (n=24), most tended to 
perceive the risk of miscarriage as low (58.3%; n=14) whereas those who did not know a 
friend or relative with this history were more likely to perceive the risk as average (40.4%; 
n=19), (p=0.001). When compared to women who knew no one with a genetic disease, 
additional analysis revealed a statistically significant difference in risk perception before 
counseling and those who knew a friend (p=0.013) or another family member not specified in 
previous choices (p=0.025). Women who indicated that they had this personal experience 
with genetic disease had lower risk perception before counseling than those who said that 
they did not know anyone with this history. Based on these results, it appears that those 
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participants who had some experience with a genetic disease felt that the risk of miscarriage 
associated with amniocentesis was lower than those who did not have connections to a 
genetic disease. If a person has experience with a genetic disease, they are more likely to be 
concerned that their own pregnancy may be affected with a genetic disease since they are 
able to call specific examples of the risk to mind (Weil, 2000). Research suggests that 
feelings towards the health of the pregnancy influence the decisions that women make 
regarding prenatal procedures: if women feel like the pregnancy is healthy, then 
amniocentesis is considered unnecessary in their minds (Markens et. al., 2010). Perhaps 
having a personal representation of genetic disease anchors women to a higher perception of 
the risk of genetic disease in their pregnancy, therefore causing the amniocentesis risk to 
seem smaller in comparison. In turn, they may have a stronger desire to undergo prenatal 
testing so that they are prepared for the potential diagnosis of a genetic condition.  
There was also a statistically significant association between risk perception and the 
number of living children a participant had (p=0.038). As indicated in Table 13, 45 women 
had 1 or 2 living children. Women who had one living child (n=28) were more likely to view 
the risk as lower than nulliparous women.  Research suggests that nulliparous women are 
more likely to be undecided about whether or not to proceed with amniocentesis than those 
who have children (Vergani et. al., 2002). Perhaps individuals who already have a child are 
less scared about losing a pregnancy as a result of an invasive diagnostic procedure.  
Risk perception was stratified by a number of factors including demographics, 
discussions with various individuals about amniocentesis, personal experience with genetic 
counseling, previous education about amniocentesis, and personal experience with 
amniocentesis, and no other factors were found to be statistically significant. Therefore, what 
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anchors each person to a certain risk perception appears to be multifaceted and individual. A 
person’s individual life experiences and internal assessments influence their ultimate risk 
perception and these experiences are diverse (Weil, 2000). Research suggests that women 
making decisions regarding prenatal testing tend to rely on highly personal opinions, such as 
ethical convictions and emotional responses to invasive testing (Garcia et. al., 2007). Because 
risk perception is apparently such a personalized phenomenon, it highlights the need for 
highly trained health professionals such as genetic counselors to elucidate the factors for each 
patient and tailor the details of the session for the patient’s individual needs.  
 
Miscarriage Quantification and Risk Perception After Counseling 
 We also aimed to determine the participants’ perception of miscarriage risk after 
counseling. The majority of patients perceived the risk in the correct numeric range of 
between 0% and 1% after counseling (73.3%; n=66). This figure is significantly increased 
from the 58.3% that indicated <1% before the genetic counseling session (p<0.0001). 
Therefore, patients’ perception of the numerical risk associated with amniocentesis is more 
likely to be in the correct range after counseling. While many patients had difficulty 
describing the numeric risk of amniocentsis, they appeared to have a general understanding 
that the risk is relatively low (1% or less). Genetic counselors use their specialized training to 
ascertain the patient’s understanding of the topics discussed during the session, including the 
risk associated with invasive procedures. This training and preparation allows the counselor 
to provide the information in the most effective way for each patient (Weil, 2000). Because a 
higher percentage of patients are correct in their risk quantification post-counseling, this may 
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indicate that the counseling session is a good source of education for patients seeking 
information about prenatal diagnostic procedures.  
 Four participants (4.4%) indicated that the risk of miscarriage associated with 
amniocentesis was between 81 and 100% after counseling. One of these participants 
indicated that she thought 1 out of 1000 procedures would result in a miscarriage, but also 
wrote that the risk of miscarriage was 99%. Another participant indicated that she believed 
50 out of 1000 procedures would end in miscarriage (5%), but converted this number to 
95.2% on the survey. These cases are clear examples of non-comprehension of the 
mathematical concepts needed to covert a ratio to a percentage. This finding is not 
unexpected because previous studies have shown that people have difficulty with fractions 
(Gates, 2004; Stevens et. al., 2008). Two other participants indicated that the risks were 90% 
and 98%, with no numeric quantification for comparison. None of these participants 
completed the miscarriage risk quantification question in the first portion of the survey. 
Therefore, we cannot determine if the post-counseling risk quantification responses are 
different than the patient’s initial belief regarding miscarriage risk before counseling. 
  
Factors that Potentially Anchor Miscarriage Risk Perception After Counseling 
There was a statistically significant association between participants’ perception of 
the risk after the genetic counseling session and their plan about whether or not to proceed 
with amniocentesis (p=0.017). Approximately equal numbers of participants indicated that 
they would proceed with amniocentesis (n=37) and would not proceed with amniocentesis 
(n=38). Participants who indicated that they would proceed with amniocentesis were more 
likely to view the risk as very low (45.9%; n=17) or low (27%; n=10) whereas those 
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participants who did not wish to proceed with amniocentesis were more likely to indicate 
values on the higher side of the scale (p=0.004). These results indicate that women who 
desire amniocentesis perceive the risk as lower than those who do not want to undergo the 
procedure. If a woman has decided she wants to proceed with amniocentesis, she may want 
to justify this decision in her mind by indicating that she perceives the risk as lower than a 
woman who has decided not to undergo the procedure. When decisions are made, individuals 
often must provide justification for those decisions due to pressures from society, authority, 
or self (Huber, Bar, & Huber, 2009). In the case of amniocentesis, a woman may have to 
provide justification of her decision to herself, her doctor, her family, or her spouse.  
 Women who stated that they wanted to proceed with amniocentesis because they 
wanted to know whether or not the pregnancy was affected with a chromosomal problem 
were significantly more likely to perceive the miscarriage risk associated with amniocentesis 
as low (p=0.015). This finding may be further confirmation that certain aspects of a person’s 
life experiences are used during risk perception and decision-making (Slovic, The Perception 
of Risk, 2000). Perhaps some women anchor to uncertainty of aneuploidy in the pregnancy 
and minimize the risk associated with amniocentesis. Further studies are needed to examine 
how much weight individuals place on certain risks in the decision-making processes.  
  
Changes in Miscarriage Risk Perception 
 A large number of participants’ view of the risk of amniocentesis remained 
unchanged after genetic counseling (60%; n=39).  Therefore while significantly more 
participants knew the true numeric risk (p<0.0001), their perception of the risk remained 
unchanged. This finding is particularly interesting because it appears that the genetic 
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counseling session has little effect on the perception of risk of many patients, even though 
much of the session is typically focused on a discussion of aneuploidy, amniocentesis, and 
miscarriage risk. This finding may indicate that many patients’ feelings about the miscarriage 
risk and amniocentesis procedure are rigid before they speak with a counselor, and those 
discussions with the counselor have little to no influence on their final perception. Perhaps 
patients use the information that the counselor provides as further “proof” of the acceptability 
of their decision. For example, if the patient perceives the risk of miscarriage associated with 
amniocentesis as high and does not feel that they want to proceed with the amniocentesis, 
they may focus on the possibility of miscarriage due to the procedure during the session as 
further justification for their perception, whereas those who are more anxious about the 
possibility of a chromosomal condition may choose to interpret that risk as high and the risk 
of amniocentesis as low. Ultimately, participants appeared to be anchored to a prior concept 
regarding the risk (Tversky & Kahneman, 1974) and the genetic counseling session had 
minimal effect on this anchor for the majority of patients in this study.  
 Participants whose risk perception changed after the counseling session were 
significantly more likely to reduce their risk perception: of those who changed their 
perception (n=26), 76.9% (n=20) lowered their risk perception after counseling (p<0.0001). 
Therefore, when the counseling session had an influence on the patient’s risk perception, it 
tended to lower the patient’s perception of the risk. Perhaps the risk that is quoted in the 
genetic counseling session is smaller than the one that the patient is anticipating, which 
causes the patient’s perception to be lower after counseling. Further study is needed to 
investigate the cause of the lowered risk perception since few factors were found to be 
associated with change. 
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When comparing whether women who changed their risk perception were more likely 
to be influenced by a certain factor, three factors were found to be statistically significant: 
whether or not the participant knew someone besides the relationships listed who had a 
personal history or child with a genetic condition (n=5; p=0.036), total number of living 
children (p=0.002), and total stillbirths (n=2; p<0.0001). However, given the small sample 
sizes it is difficult to determine whether or not these significant factors are true or due to 
chance.  
 
Strengths and Limitations of the Current Study 
 The relatively large and diverse sample set in this study allows for reasonable 
conclusions to be drawn that are likely applicable to other patient populations around the 
country. Given that 35.1% of participants were Caucasian, 26.1% were Hispanic, and 24.3% 
were African American and we were still unable to find significant differences between the 
racial groups that were anchoring risk perception, it seems that risk perception is 
individualized by person and not likely due to cultural background. Another strength of the 
study was the capture of risk perception both pre- and post-counseling. There is limited data 
regarding change in miscarriage risk perception associated with amniocentesis. This study 
shows that when risk perception is changed, it tends to be decreased, but that risk perception 
is unchanged for many seeking genetic counseling.  
There were also several limitations of this study. The data was gathered via a self-
administered questionnaire, which caused participants to interpret questions without any 
guidance. Sixty-six participants left the quantification question blank on the first portion of 
the survey and 14 left the question blank on the second portion. This may be due to the 
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intimidation individuals feel regarding mathematical concepts or because they were afraid of 
being incorrect. Future studies may wish to explore alternate methods of assessing numeric 
risk to improve participation. In addition, we did not account for the number of patients who 
refused to participate in the study; therefore, those who completed the survey may have been 
motivated to do so and may bias the results of the study. This study was also conducted at 
multiple satellite clinics in the Houston area, each of which is staffed by different personnel 
responsible for survey distribution. Lack of consistency of survey distribution may have 
biased who received the survey and what percentage of the patient population of a given 
clinic completed the questionnaire.  
 As women who were counseled with use of an interpreter were excluded, further 
study may be needed in other populations that may be seen for genetic counseling, such as 
non-English-speaking patients who may be less familiar with amniocentesis. It would be 
useful to confirm the results of this study in other populations to determine if the anchoring 
effects are more homogenous. 
 
Conclusion 
In conclusion, this study aimed to determine how prenatal patients perceived the risk 
of miscarriage associated with amniocentesis before and after a genetic counseling session. 
The study also attempted to determine what factors anchor a woman’s perception of that risk. 
In general, most women perceived the risk as low or average pre-counseling and were likely 
to indicate the risk of amniocentesis as <1% risk. A significantly higher percentage of 
patients correctly identified the numeric risk as <1% post-counseling when compared to pre-
counseling (p<0.0001). However, the study found that the majority of patients’ feeling about 
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the risk perception did not change after the genetic counseling session (60%), regardless of 
how they perceived the risk before discussing amniocentesis with a genetic counselor. Of 
those whose perception changed, it was significantly lower post-counseling (p<0.0001). Few 
factors were found to influence risk perception in a significant manner. One significant factor 
was that those with a friend or relative with a personal or family history of a genetic disorder 
were more likely to perceive the risk as low (p=0.001). In addition, having a child already 
was likely to make a woman perceive the risk as low (p=0.038). The lack of overall 
consistent significant factors may reinforce the importance of genetic counseling to elucidate 
individual concerns.  
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Appendix A 
University of Texas-Health Sciences Center Houston 
Risk Perception Associated with Amniocentesis 
 
Amniocentesis Information: 
The purpose of this survey is to understand the thoughts of pregnant women about the risk 
associated with amniocentesis. An amniocentesis (sometimes called the needle test) is a 
procedure used to tell if the baby has certain genetic conditions, such as Down syndrome. 
During an amniocentesis, the doctor uses a needle to remove a few teaspoons of fluid from 
the water sac. 
 
 
1. Was this the first time you heard of an amniocentesis? 
    Yes  (If yes, proceed to question #18)                 
  No 
 
2. If 1,000 women have an amniocentesis, how many of the 1,000 will have a 
miscarriage due to the amniocentesis? 
_____________ out of 1,000 women will have a miscarriage after an 
amniocentesis  
( if  you would prefer, you can provide a percentage: 
__________%) 
 
3. How do you feel about the risk of miscarriage from amniocentesis? It is:  
                  
 
 
4. Who have you talked to about the amniocentesis?  (Check all that apply) 
 My doctor                                My friends                                                                    
 My husband/partner            My co-workers                   
 My mother               My sister 
 No one (Please skip to question #6) 
 Other: ___________________________________ 
 
5. If you talked with someone about the amniocentesis, did they suggest that you get the 
amniocentesis? 
 Yes                                         
 No                    
 They did not give a suggestion 
Very Low                       Low  Average     High         Very High 
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6. Where have you read information about amniocentesis? (Check all that apply) 
 Book (ex. What To Expect When You’re Expecting)              
 Pamphlet              
 Internet website 
 None                       
 Other: ______________________________________________________ 
 
7. Have you ever had an amniocentesis performed in a previous pregnancy? (Check one) 
 Yes                       
 No (If no, please skip to question #11)                        
 I don’t know 
 
8. If yes, how many times have you had an amniocentesis performed in a previous 
pregnancy? (Check one) 
 One                     
 Two                      
 Three or more 
 
9. What did the amniocentesis results show? (Check all that apply) 
 No problem (normal chromosomes) 
 Down syndrome                                      
 Trisomy 18                                                  
 Trisomy 13      
 Extra or missing sex chromosome problem (such as Turner or Klinefelter 
syndrome)  
 Neural tube/open spine defect (spina bifida)    
 I don’t know   
 Other: ___________________________________________________ 
 
10. Did you have any complications after the amniocentesis? 
 Yes  (if yes, please check which complications below)                   
 Bleeding     
 Fluid Leakage   
 Fever    
 Miscarriage 
 Other: 
___________________________________________________ 
 No 
 
11. Do you have friends or relatives who have had the amniocentesis? 
 Yes (if yes, please check who below) 
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 Friend             
 Mother             
 Sister              
 Sister-in-law          
 Another family member         
 Coworker                            
 Other: _________________________________________              
  No (If no, please skip to question #14) 
  I don’t know 
 
12. Did the amniocentesis show any problems with their baby? 
  Yes                      
  No                         
  I don’t know 
 
13. Did your friend/relative/coworker have any complications from the amniocentesis? 
 Yes  (if yes, please check which complications below)                   
 Bleeding     
 Fluid Leakage   
 Fever    
 Miscarriage 
 Other: _______________________________________________ 
 No 
 
14. Do you have any friends/relatives/coworkers who have a child or a personal history 
of a genetic disorder or birth defect? 
 Yes (if yes, please check who below) 
 Friend             
 Mother             
 Sister              
 Sister-in-law          
 Another family member         
 Coworker                            
 Other: _______________________________________________              
  No  
 
15. What genetic disorder or birth defect does your friend/relative/coworker have? 
Please describe: 
___________________________________________________ 
16. Have you ever had genetic counseling before today? 
 Yes 
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 If yes, when did you have genetic counseling (year): 
________________ 
If yes, for what reason did you have genetic counseling: 
             Advanced Maternal Age (over 35)    
 Positive blood test for Down syndrome or trisomy 18  
  
 Positive blood test for open neural tube defect/spina bifida
   
 Family history of a genetic condition 
 Other: ______________________________________ 
 No                        
 
17. Have any of your children been diagnosed with a genetic disorder or a birth defect 
(such as cystic fibrosis, sickle cell disease, heart defect, cleft lip, Down syndrome, 
etc)? (Check one) 
 
 Yes  - please specify the disorder or birth defect: _____________       
 No                                      
 I don’t have any children 
 
 
 
 
Demographics: 
 
18. How old are you? _______________ years old 
 
19. What is your race/ethnic background? (Check one)  
 African-American       
 Hispanic         
 Asian     
 Caucasian       
 Other:  ___________________________________ 
 
20. What is the highest grade you have completed ?(Check one) 
  Some high school     
  High School      
  Some college    
  College      
  Graduate School 
 
21. What is your total combined annual household income (check one): 
66 
 
 < 30,000     
 30,000 – 60,000      
 60,000 – 100,000     
 > 100,000  
 
22. What is your religious affiliation (Check one) 
 Protestant           
 Catholic         
 Jewish          
 Muslim     
 Buddhist 
 Hindu   
 None  
 Other: ___________________ 
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Appendix B 
University of Texas-Health Sciences Center Houston 
Risk Perception Associated with Amniocentesis 
 
During the genetic counseling session, the genetic counselor discussed the amniocentesis 
with you. 
 
1. If 1000 women have an amniocentesis, how many of the 1000 will have a miscarriage 
due to the amniocentesis? 
_____________ out of 1000 women will have a miscarriage after an amniocentesis  
(If you would prefer, you can provide a percentage: __________%) 
 
 
2. How do you feel about the risk of miscarriage from amniocentesis? It is:  
                  
 
 
3. Is the amniocentesis is something that you plan to do in this pregnancy? 
 Yes (if yes, please check all that apply) 
 I need to know if the baby has a genetic condition like Down 
syndrome before birth 
                       I think that the risk associated with amniocentesis was low. 
                        I had one in a previous pregnancy and everything was fine 
                   Other: 
__________________________________________________ 
 No (if no, please check all that apply) 
 The risk of miscarriage is too high 
              I do not like needles 
 It doesn’t matter to me if the baby has a genetic condition like Down 
syndrome 
              I had a friend/relative with a problem after amniocentesis 
             I don’t know what the amniocentesis will tell me about the baby 
             I don’t think that my baby has a problem   
 Other: __________________________________________________ 
                   Unsure/Not at this visit (if unsure, please check all that apply) 
     I need to speak to my husband/partner 
 I want to wait and see if there are any abnormalities on ultrasound 
first  
         Other: __________________________________________ 
  
 
Very Low                       Low  Average  High         Very High 
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Appendix C 
University of Texas-Health Sciences Center Houston 
Influence of Anchoring on Miscarriage Risk Perception Associated with Amniocentesis 
 
1. Risk of miscarriage from amniocentesis quoted to patient:   
  1 in 200  1 in 250     1 in 300  1 in 500 other: 
_______________ 
 
2. Which of the following factors (if any) do you feel influenced the patient’s decision 
regarding amniocentesis:  
(check all that apply) 
 Risk of miscarriage 
 Prior amniocentesis 
  Prior miscarriage 
  Prior child with a birth defect/genetic condition 
 Family history of prior child with a birth defect/genetic condition 
 Information patient read about amniocentesis 
 Religious conviction 
 Use of needle 
Opinion of: 
                     Friend             
   Mother             
   Father             
   Sibling         
       Another family member              
   Coworker        
              Patient’s physician 
   Other:________________________ 
 Other: __________________________________________ 
3.  Is the patient having amniocentesis? 
 Yes (if yes, due to) 
 She expressed a need to know if the baby has a genetic condition 
before birth 
                       She felt that the risk associated with amniocentesis was low. 
                        She had an amniocentesis previously 
                   Other: ______________________________________________ 
 No (if no, due to) 
 The risk of miscarriage is too high 
               Does not like needles 
 It doesn’t matter to the patient if the baby has a chromosome 
problem like Down syndrome 
               She had a friend/relative with a problem after amniocentesis 
               She did not understand the information about amniocentesis 
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              She did not believe that the baby had a chromosome problem  
 Other: 
__________________________________________________ 
                       Unsure/Not at this visit (if unsure, due to) 
     She needed to speak with her husband/partner 
 She wanted to see if there are any abnormalities on ultrasound first  
         Other: ________________________________________________ 
  
4. Counselor for the session: 
 Carter   
 Czerwinski  
 Hoskovec  
 Singletary   
 Sullivan    
 Wilson 
 
5.  Did the genetic counselor perform the majority of the session?  
 
 Yes     
 No (if no, then who) 
 First year genetic counseling student 
 Second year genetic counseling student 
 Resident 
 Fellow 
 
6. Were there any other factors that you felt influenced the session?  If so, please 
comment: 
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________
_____________________________________________________________________
_______________ 
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Appendix D 
University of Texas-Health Science Center Houston 
Risk Perception Associated with Amniocentesis 
 
Dear Potential Study Participant, 
You are being invited to take part in a research study called Influence of Anchoring on 
Miscarriage Risk Perception Associated with Amniocentesis. We are interested in what 
factors affect a woman’s perception of the miscarriage risk associated with a test called 
amniocentesis. The people in charge of this research project are Regina Nuccio and Claire 
Singletary at the University of Texas Medical School Houston. For this research study, they 
will be called the Principal Investigators, or PIs. 
Your decision to join this research study is voluntary. You may refuse to take part, or choose 
to stop taking part at any time. Your decision about participation in this study or answering 
questions will not change the care or services that you receive from the University of Texas 
Health Science Center Houston.  
This research study involves taking an anonymous survey to look at factors that affect what 
people think about the risk of miscarriage risk associated with amniocentesis. Amniocentesis 
is a prenatal procedure that involves inserting a needle into a woman’s abdomen in order to 
remove 4 teaspoons of liquid from the sac that the baby floats in. A test is then run on the 
cells in this liquid that can tell if the baby has a chromosome problem, such as Down 
syndrome. 
If you agree to join this study, you will be given the survey in two parts. The first part will be 
given to you before your genetic counseling session. This part of the survey includes 
questions about people you may or may not have discussed the amniocentesis with as well as 
personal, medical, family, and pregnancy history. The second part will be given to you after 
the genetic counseling session while you are waiting for your ultrasound. This part of the 
survey is shorter than the first and will ask you some of the same types of questions as the 
first part. Both parts of the survey will take about 10 minutes to complete. Your responses 
will be confidential and will be viewed only by the researchers involved in the study. You 
will not be asked to include your name or any information that will personally identify you. 
After completing the survey, it will be placed in a sealed envelope for the Principal 
Investigators. 
Although the results of this study will be useful for doctors, other health professionals and 
future pregnant women, there may be no direct benefit to you for participating in this study. 
There is no physical danger in joining this study. Some of the questions on the survey may 
make you feel uncomfortable. You can refuse to answer or skip any questions or stop taking 
the survey at any time. If you decide to participate in the study, it is very important that you 
answer as honestly as you can to the questions that are asked. 
It will not cost you anything to join this study. You will not be paid to complete the survey.  
All surveys will be kept in a secured area that is only accessible to the research staff. You 
will not be personally identified in any reports or publications of this study. 
If you have any questions or would like more information, please contact Regina Nuccio, BS 
or Claire Singletary, MS, CGC at (713) 500-5760. If you would like to withdraw from the 
study at any time, please contact Ms. Nuccio or Ms. Singletary at the above number. 
If you are willing to take part in our study, please complete and return the survey in the 
enclosed envelope to the front desk personnel or genetic counselor. 
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Thank you very much for considering this invitation to participate in our study. 
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